Trials / Completed
CompletedNCT02128919
Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Nathan Kline Institute for Psychiatric Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a study of the effects of tDCS on smoking, craving for cigarettes, cognition, and psychiatric symptoms in schizophrenic patients who are current smokers or have a history of regular cigarette smoking. It assesses smoking with CO monitoring, nicotine and nicotine levels, and craving with QSU scale and response to craving slides. Cognition is measured by MCCB, symptoms are measured by PANSS and hallucination scale. This is a double-blind sham-controlled study with active tDCS 2ma or 20 minutes over 5 days, and sham tDCS for 40 seconds on each sham occasion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | tDCS | Transcranial Direct Current Stimulation |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-05-01
- Last updated
- 2017-08-30
- Results posted
- 2017-08-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02128919. Inclusion in this directory is not an endorsement.